Author:
Parente Lynn,Uyehara Catherine,Larsen Wilma,Whitcomb Bradford,Farley John
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynaecology,General Medicine
Reference13 articles.
1. Anderson GL, Judd HL, Kaunitz AM, Barad DH, Beresford SA, Pettinger M, et al (2003) Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women’s health initiative randomized trial. JAMA 290(13):1739–1748. 1538-3598, (Electronic), Notes: CORPORATE NAME: Women’s Health Initiative Investigators
2. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 288:321–333 Notes: CORPORATE NAME: Writing Group for the Women's Health Initiative Investigators
3. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H et al (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the women’s health initiative randomized controlled trial. JAMA 291(14):1701–1712. 1538-3598, (Electronic) Notes: CORPORATE NAME: Women's Health Initiative Steering Committee
4. Buist DS, Newton KM, Miglioretti DL, Beverly K, Connelly MT, Andrade S et al (2004) Hormone therapy prescribing patterns in the United States. Obstet Gynecol 104(5 Pt 1):1042–1050. 0029-7844 (Print)
5. Bilgrami I, Blower K, Feng J, Stefanko G, Tan E (2004) Changes in the use of hormone replacement therapy in New Zealand following the publication of the Women’s Health Initiative trial. N Z Med J 117(1206):U1175. 1175-8716 (Electronic)
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献